Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID05149196

Impact of Goal-directed Hemodynamic Management on Acute and Persistent Kidney Injury After Radical Nephrectomy or Nephroureterectomy

Led by Peking University First Hospital · Updated on 2025-06-03

1724

Participants Needed

1

Research Sites

104 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are investigating the effects of goal-directed hemodynamic management on kidney injury in patients undergoing radical nephrectomy or nephroureterectomy, surgeries performed for renal cell carcinoma and upper tract urothelial carcinoma. These surgeries often lead to acute kidney injury (AKI), which increases the risk of chronic kidney disease (CKD). This study aims to determine if managing blood flow and pressure during surgery can reduce AKI occurrence and improve long-term kidney health. The study compares two approaches during surgery: one group receives goal-directed hemodynamic management involving active hydration, inotropes (dobutamine), and forced diuresis to maintain specific targets for pulse pressure variation, mean arterial pressure, and urine output. The other group receives routine care with standard fluid infusion and blood pressure targets. Post-surgery, blood pressure is carefully managed for 48 hours in the goal-directed group, while routine care continues for the other group. Participants will be monitored for up to 7 days after surgery to assess the incidence of acute kidney injury, and for up to 2 years to evaluate new or worsening chronic kidney disease. Additional outcomes include heart injury, delirium, surgical site infections, and survival without major events. The study involves regular monitoring of vital signs, kidney function, and other health assessments during hospitalization and follow-up visits to evaluate the long-term effects of the different management approaches.

CONDITIONS

Brief Title

Goal-directed Hemodynamic Management and Kidney Injury After Radical Nephrectomy or Nephroureterectomy

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age of 18 years or older
  • Scheduled to undergo unilateral radical nephrectomy for renal cancer
  • Scheduled to undergo unilateral radical nephroureterectomy for upper tract urothelial carcinoma
Not Eligible

You will not qualify if you...

  • Diagnosed with chronic kidney disease stage 4 or 5 (GFR <30 ml/min/1.73m2) before surgery
  • Uncontrolled severe hypertension (systolic blood pressure ≥180 mmHg or diastolic blood pressure ≥110 mmHg)
  • Combined cardiovascular diseases with Revised Cardiac Risk Index (RCRI) >1 or metabolic equivalents (METs) <4
  • Unable to communicate due to severe dementia, language barrier, or end-stage disease before surgery
  • Other conditions considered unsuitable for inclusion as specified by investigators

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Surgery and Immediate Post-operative Care

Duration - Surgery day and first 48 hours after surgery

Participants undergo radical nephrectomy or nephroureterectomy surgery. During anesthesia, participants receive either targeted hemodynamic management involving active hydration, inotropes, and forced diuresis to maintain specific blood pressure and urine output targets, or routine care according to standard practice. Hemodynamic management continues during the first 48 hours after surgery.

1 surgical visit and hospital stay including post-operative care

Post-operative Follow-up

Duration - Up to 2 years after surgery

Participants are monitored for acute kidney injury, myocardial injury, delirium, and surgical site infections following surgery. Kidney function and possible chronic kidney disease progression are assessed over time.

Visits up to 7 days, 30 days, 3 months, and periodic assessments up to 2 years

Trial Site Locations

Total: 1 location

1

Beijing University First Hospital

Beijing, Beijing Municipality, China, 100034

Actively Recruiting

Loading map...

Research Team

D

Dong-Xin Wang, MD,PhD

Q

Qiongfang Wu, MD

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

PREVENTION

Number of Arms

2

Similar Trials

A Cardiometabolic Health Program Linked With Clinical-Commun...

Hypertension

Actively Recruiting

3 locations

A Randomized Clinical Trial to Define the Best Strategy for ...

Heart Failure

Actively Recruiting

6 locations

A Double-blind Non Inferiority Clinical Trial to Compare the...

Debulking Surgery for Ovarian Cancer

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Post-operative acute kidney injury in patients with renal cell carcinoma is a potent risk factor for new-onset chronic kidney disease after radical nephrectomy.

Ajin Cho, Jung Eun Lee, Gee-Young Kwon...

https://pubmed.ncbi.nlm.nih.gov/21406544

Risk factors for acute kidney injury after radical nephrectomy and inferior vena cava thrombectomy for renal cell carcinoma.

Sung Shin, Youngjin Han, Hojong Park...

https://pubmed.ncbi.nlm.nih.gov/23591189

Long-term risk of adverse outcomes after acute kidney injury: a systematic review and meta-analysis of cohort studies using consensus definitions of exposure.

Emily J See, Kushani Jayasinghe, Neil Glassford...

https://pubmed.ncbi.nlm.nih.gov/30473140

Mild Acute Kidney Injury after Noncardiac Surgery Is Associated with Long-term Renal Dysfunction: A Retrospective Cohort Study.

Alparslan Turan, Barak Cohen, Janet Adegboye...

https://pubmed.ncbi.nlm.nih.gov/31929326

Relationship between intraoperative mean arterial pressure and clinical outcomes after noncardiac surgery: toward an empirical definition of hypotension.

Michael Walsh, Philip J Devereaux, Amit X Garg...

https://pubmed.ncbi.nlm.nih.gov/23835589